Dialysis News and Research

Latest Dialysis News and Research

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Alexion Pharmaceuticals, Inc. today announced that its two open-label Phase 2 studies investigating eculizumab (Soliris) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) have met the primary and key secondary endpoints with high clinical and statistical significance, in interim analyses.

21 Oct 2010

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott today announced financial results for the third quarter ended Sept. 30, 2010.

20 Oct 2010

Rockwell Medical announces design of Phase III development program for Soluble Ferric Pyrophosphate

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, announced today the design of its Phase III development program for Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic.

20 Oct 2010

Aspirin before cardiac surgery reduces postoperative cardiocerebral complications

A study presented at the American Society of Anesthesiologists 2010 Annual Meeting revealed that use of aspirin before cardiac surgery reduced postoperative cardiocerebral complications, including stroke, myocardial ischemia, heart block and cardiac arrest by more than 33 percent when compared to patients who did not use aspirin.

20 Oct 2010

New book focuses on clinical importance of online HDF technique

Hemodiafiltration (HDF) for the treatment of end-stage renal disease patients is predominantly performed in European countries and in Japan, with some differences in technique such as rate of blood flow and dialysis fluid delivery systems.

20 Oct 2010

Amgen to review study results of ESA in chronic renal failure patients with FDA and CRDAC

Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).

19 Oct 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of BARACLUDE for the treatment of chronic hepatitis B (CHB) in adult patients with decompensated liver disease.

18 Oct 2010

FDA plans to revoke knee implant approval following intense political pressure for its approval

The Food and Drug Administration on Thursday said it planned to revoke a medical-device company's right to sell a knee implant called Menaflex after an unprecedented yearlong review concluded the agency erred in allowing it on the market

18 Oct 2010

Crosstex International introduces customized surgical masks

Cantel Medical Corp., announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The SecureFit™ series of masks addresses scientific research that points to poorly fitting masks as a major hindrance to their effectiveness.

15 Oct 2010

Improving muscle mass benefits kidney disease patients

Kidney disease patients are healthier and live longer if they've beefed up their muscles, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that patients may benefit from pumping iron or taking medications to boost their lean body mass.

14 Oct 2010

2010 edition of The AHLA/BVR Guide to Healthcare Valuation

Business Valuation Resources (BVR) and the American Health Lawyers Association (AHLA) are pleased to announce The AHLA/BVR Guide to Healthcare Valuation, 2010 Edition, edited by Mark Dietrich, CPA, ABV.

13 Oct 2010

Study examines restrictive strategy of RBC transfusion in patients undergoing elective cardiac surgery

Use of stricter guidelines for the use of red blood cell transfusions for patients undergoing cardiac surgery was associated similar rates of death and severe illness compared to patients who received more transfusions, according to a study in the October 13 issue of JAMA. Another study in this issue of JAMA examines the variation in the use of blood transfusions for patients undergoing cardiac surgery.

13 Oct 2010

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Donor kidneys can be successfully transplanted even if there is strong tissue incompatibility between donor and recipient. An interdisciplinary working group headed by Dr. Christian Morath, senior consultant at the Department of Nephrology at Heidelberg University Hospital (Medical Director: Professor Dr. Martin Zeier) and Professor Dr. Caner S-sal, head of antibody laboratory in the Department of Transplantation Immunology, showed in a study of 34 sensitized high-risk patients that the success rate in these patients was not different from the success rate of patients with a low immunological risk.

13 Oct 2010

ALung Technologies announces closing of $14 Million Series A financing round

ALung Technologies, Inc. today announced that the Company has closed a $14 Million Series A financing round. The investment will support ongoing clinical trials of the Hemolung™ Respiratory Assist System and its subsequent commercialization. The Company's Hemolung device is expected to help many patients with acute respiratory failure to avoid intubation and invasive mechanical ventilation.

11 Oct 2010

AngioDynamics reports 3% increase in net sales for fiscal 2011 first quarter

AngioDynamics, a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today reported financial results for the fiscal 2011 first quarter ended August 31, 2010 that were in line with the preliminary results reported on September 7, 2010.

7 Oct 2010

Lowering blood pressure may reduce risk of kidney disease progression

Keeping blood pressure at a low level in African-Americans with kidney disease may slow the progression of the condition in patients with proteinuria, UT Southwestern Medical Center researchers found in a national study published in The New England Journal of Medicine.

7 Oct 2010

Affymax receives arbitration panel decision related to dispute against JNJ subsidiaries

Affymax, Inc. today announced that it has received a decision from the arbitration panel reviewing its dispute against certain subsidiaries of Johnson and Johnson (JNJ).

7 Oct 2010

New report focuses on management of renal anemia amongst dialysis, later stage CKD patients

BioTrends Research Group, Inc. recently published its TreatmentTrends: Renal Anemia in China report. This report is based on survey results from 150 nephrologists in clinical practice in China and qualitative interviews conducted with ten thought leaders in nephrology. The report examines the demographics of nephrology practice in China and focuses specifically on the management of renal anemia amongst dialysis and later stage chronic kidney disease patients.

7 Oct 2010

Podocytes key to development of kidney failure in diabetes

Diabetes is the leading reason for kidney failure in the world, resulting in patients requiring dialysis or kidney transplantation. New research has found a cell in the kidney called the podocyte could be the key to understanding why this happens.

6 Oct 2010

Dialysis News and Research

Latest Dialysis News and Research

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Rockwell Medical announces design of Phase III development program for Soluble Ferric Pyrophosphate

Aspirin before cardiac surgery reduces postoperative cardiocerebral complications

New book focuses on clinical importance of online HDF technique

Amgen to review study results of ESA in chronic renal failure patients with FDA and CRDAC

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

FDA plans to revoke knee implant approval following intense political pressure for its approval

Crosstex International introduces customized surgical masks

Improving muscle mass benefits kidney disease patients

2010 edition of The AHLA/BVR Guide to Healthcare Valuation

Study examines restrictive strategy of RBC transfusion in patients undergoing elective cardiac surgery

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

ALung Technologies announces closing of $14 Million Series A financing round

AngioDynamics reports 3% increase in net sales for fiscal 2011 first quarter

Lowering blood pressure may reduce risk of kidney disease progression

Affymax receives arbitration panel decision related to dispute against JNJ subsidiaries

New report focuses on management of renal anemia amongst dialysis, later stage CKD patients

Podocytes key to development of kidney failure in diabetes

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in